GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Terns Pharmaceuticals Inc (STU:430) » Definitions » Price-to-Operating-Cash-Flow

Terns Pharmaceuticals (STU:430) Price-to-Operating-Cash-Flow : (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Terns Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-12-15), Terns Pharmaceuticals's share price is €6.45. Terns Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.92. Hence, Terns Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Terns Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:430's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.685
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Terns Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Sep. 2024 was €-0.19. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.92.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 10.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.80% per year.

During the past 6 years, Terns Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 21.00% per year. The lowest was -34.70% per year. And the median was 10.30% per year.


Terns Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Terns Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terns Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Terns Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - - - -

Terns Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Terns Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Terns Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terns Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Terns Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Terns Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.



Terns Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Terns Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=6.45/-0.92
=

Terns Pharmaceuticals's Share Price of today is €6.45.
Terns Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.92.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Terns Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Terns Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Terns Pharmaceuticals Business Description

Traded in Other Exchanges
Address
1065 East Hillsdale Boulevard, Suite 100, Foster, CA, USA, 94404
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Terns Pharmaceuticals Headlines

No Headlines